Back

Safety and effectiveness of angiotensin receptor-neprilysin inhibitors in patients with heart failure with preserved ejection fraction (ARNI-PRESERVED study).

18 March 2022 (19:20 - 19:25)
Organised by:
Congress Presentation Part of: Best ePoster in Insights on classical and new aspects of acute care Acute Cardiac Care ACVC Premium Access ESC Acute CardioVascular Care 2022

About the speaker

Photo
Doctor Pankaj Jariwala

Yashoda Hospital Hyderabad, Hyderabad (India)

4 More presentations in this session

Presentation thumbnail
Outcomes in patients with acute heart failure treated with levosimendan: the impact of right ventricular function.
Doctor K. Tapia (Buenos Aires, AR)
Presentation thumbnail
Time is kidney: relation between pain-to-balloon time and acute kidney injury among ST segment elevation myocardial infarction patients undergoing primary percutaneous intervention.
Doctor D. Zahler (Tel Aviv, IL)
Presentation thumbnail
Cardiovascular disease in critically ill COVID-19 patients.
Doctor V. Lopes (Coimbra, PT)
Presentation thumbnail
Application of artificial intelligence to optimize the diagnosis and treatment of acute coronary syndrome: a real experience.
Doctor D. Mota (Sao Paulo, BR)

Access the full session

Session thumbnail
Best ePoster in Insights on classical and new aspects of acute care

The Event

Event poster

ESC Acute CardioVascular Care 2022

18 March 2022 19:20 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources